Renal Denervation Systems Market to Reach US$ 1,723.6 Million by 2027, with a CAGR of 40.67%

Renal Denervation Systems Market to Reach US$ 1,723.6 Million by 2027, with a CAGR of 40.67%
The global renal denervation systems market size reached US$ 218.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,723.6 Million by 2027, exhibiting a growth rate (CAGR) of 40.67% during 2022-2027.

According to the latest report by IMARC Group, titled, “Renal Denervation Systems Market Size: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027″,the global renal denervation systems market size reached US$ 218.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,723.6 Million by 2027, exhibiting a growth rate (CAGR) of 40.67% during 2022-2027.

Renal denervation (RDN) systems comprise a radiofrequency ablation that burns the nerves within the renal arteries. They produce a reduction in nerve activity to lower blood pressure. They also minimize renin secretion, improve blood flow, and stimulate natriuresis. They are used to treat refractory hypertension cases with metabolic abnormalities, sleep apnea, heart failure, chronic kidney disease, and arrhythmias, wherein optimal therapy cannot provide relief to the patients. As a result, they are widely utilized in hospitals, surgical centers, and trauma and ambulatory centers across the globe.

Report Metric

Historical: 2016-2021

Base Year: 2020

Forecast Year: 2022-2027

Request Free Sample Report:

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Renal Denervation Systems Market Trends

The increasing prevalence of lifestyle diseases, such as hypertension among the masses, on account of sedentary lifestyles, unhealthy dietary patterns, and high-stress levels represents one of the major factors positively influencing the demand for RDN systems around the world. The rising number of individuals with chronic kidney disease (CKD) and other chronic conditions is contributing to the market growth. It can also be accredited to the rising aging population, which is more prone to these medical conditions. Besides this, the growing number of airborne diseases on account of the increasing air pollution levels and the rising number of smokers and alcohol consumers is also favoring the market growth. Moreover, the expanding number of clinical trials is contributing to the market growth. In addition, the growing demand for minimally invasive (MI) surgical procedures by patients and healthcare professionals due to their associated benefits is driving the market. The increasing awareness about the clinical advantages associated with RDN systems, such as quick recovery, cost-effectiveness, and minimal complications, is also fueling the market growth. The launch of micro-infusion technology and the rising number of filings for regulatory approvals of the systems are other growth-inducing factors. Apart from this, public and private health organizations are undertaking numerous initiatives to spread awareness about renal-related disorders and available disease testing facilities, which is creating a positive outlook for the market. Furthermore, the growing use of ultrasound ablation for diagnostic imaging and treatment is propelling market growth. They are incorporated with technological advancements, such as artificial intelligence (Al), to automate time-consuming processes, such as quantification and selecting the best image slice from a third-dimensional (3D) dataset, which is providing a thrust to the market growth. Additionally, leading key players are investing in research and development (R&D) activities to introduce alternative technologies and significant improvements in the healthcare infrastructure, which is projected to impel the market growth.

Global Renal Denervation Systems Market Report Scope

Report Coverage


Market size value in 2021

US$ 218.2 Million

Market forecast in 2027

US$ 1,723.6 Million

Growth Rate

 CAGR of 40.67% from 2022-2027

Base year for estimation


Historical data


Forecast period



Global Renal Denervation Systems Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporat

The report has segmented the market on the basis on region, product type, product, technology, application and end user.

Breakup by Product Type:

  • Catheters
  • Single Electrode Catheter
  • Multi Electrode Catheter
  • RF Generator
  • Nerve Modifying Agents

Breakup by Product:

  • Symplicity
  • Vessix (V2)
  • EnligHTN
  • Paradise
  • Iberis
  • Others

Breakup by Technology:

  • Ultrasound Ablation
  • Radiofrequency Ablation
  • Microinfusion

Breakup by Application:

  • Hypertension
  • Cardiac Disorders
  • Diabetes
  • Renal Failure
  • Others

Breakup by End User:

  • Diagnostic Centers and Hospitals
  • Ambulatory Care Centers
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

If you want the latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request a free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:Market Performance (2016-2021)Market Outlook (2022- 2027)Porter’s Five Forces AnalysisMarket Drivers and Success FactorsSWOT AnalysisValue ChainComprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Reports by IMARC Group:

United States Dry Eye Syndrome Market Report 2022-2027:

India Surgical Sutures Market Report 2022-2027:

Asia Pacific Dental Implants Market Report 2022-2027:

Europe Dental Implants Market Report 2022-2027:

United States Dental Implants Market Report 2022-2027:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States